CLINICAL_TRIALS
trial_result
· 2012-04-30
Clinical Trial Update: Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 [Phase 2]
Summary
Phase 2 trial evaluating antiangiogenic therapy with bevacizumab and everolimus for hepatocellular carcinoma has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gerhard Treiber | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED